- Home
- EHAB vs CYRX Comparison
EHAB vs CYRX Comparison
Compare EHAB & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EHAB
- CYRX
- Stock Information
- Founded
- EHAB 2014
- CYRX 1999
- Country
- EHAB United States
- CYRX United States
- Employees
- EHAB N/A
- CYRX N/A
- Industry
- EHAB Hospital/Nursing Management
- CYRX Biotechnology: Pharmaceutical Preparations
- Sector
- EHAB Health Care
- CYRX Health Care
- Exchange
- EHAB Nasdaq
- CYRX Nasdaq
- Market Cap
- EHAB 409.1M
- CYRX 438.7M
- IPO Year
- EHAB N/A
- CYRX N/A
- Fundamental
- Price
- EHAB $8.01
- CYRX $8.77
- Analyst Decision
- EHAB Buy
- CYRX Strong Buy
- Analyst Count
- EHAB 3
- CYRX 10
- Target Price
- EHAB $8.67
- CYRX $11.70
- AVG Volume (30 Days)
- EHAB 551.5K
- CYRX 1.1M
- Earning Date
- EHAB 08-06-2025
- CYRX 08-05-2025
- Dividend Yield
- EHAB N/A
- CYRX N/A
- EPS Growth
- EHAB N/A
- CYRX N/A
- EPS
- EHAB N/A
- CYRX 1.35
- Revenue
- EHAB $1,037,800,000.00
- CYRX $237,879,000.00
- Revenue This Year
- EHAB $4.66
- CYRX N/A
- Revenue Next Year
- EHAB $4.99
- CYRX $9.08
- P/E Ratio
- EHAB N/A
- CYRX $6.49
- Revenue Growth
- EHAB N/A
- CYRX 24.93
- 52 Week Low
- EHAB $6.47
- CYRX $4.58
- 52 Week High
- EHAB $10.91
- CYRX $9.48
- Technical
- Relative Strength Index (RSI)
- EHAB 57.76
- CYRX 57.54
- Support Level
- EHAB $7.94
- CYRX $8.39
- Resistance Level
- EHAB $8.29
- CYRX $9.05
- Average True Range (ATR)
- EHAB 0.27
- CYRX 0.54
- MACD
- EHAB 0.09
- CYRX 0.00
- Stochastic Oscillator
- EHAB 73.36
- CYRX 69.23
About EHAB Enhabit Inc.
Enhabit Inc provides home health and hospice services in the United States. Its reportable segments are Home Health and Hospice. The Home Health segment includes a comprehensive range of Medicare-certified home nursing services for adult patients in need of care. These services include, among others, skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services. The Hospice segment focuses on the quality of life for patients who are experiencing a life-limiting illness while treating the person and symptoms of the disease, rather than the disease itself. The company generates a majority of its revenue from the Home Health segment.
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.